Hydrogen-dominant and methane-dominant small intestinal overgrowth are caused by different organisms, produce different primary symptoms, and respond to different treatments. The distinction matters because someone producing mostly hydrogen on a breath test tends toward diarrhea, while someone producing mostly methane tends toward constipation and bloating. In a large cohort study, about half of patients who tested positive produced only hydrogen, roughly 40 percent produced only methane, and the remainder produced both gases. Getting the type right steers everything from antibiotic choice to dietary strategy, and a growing body of evidence suggests a third gas, hydrogen sulfide, complicates the picture further.
Different Organisms, Different Problems
The hydrogen form of small intestinal bacterial overgrowth is caused by actual bacteria. Various species ferment carbohydrates in the small intestine and release hydrogen gas as a byproduct. The methane form, by contrast, is driven primarily by archaea, a separate domain of life altogether. The dominant player is a microbe called Methanobrevibacter smithii, which does not ferment food directly but instead consumes the hydrogen produced by other organisms and converts it into methane. Because archaea are not bacteria, researchers have pushed to rename the methane form “intestinal methanogen overgrowth,” or IMO, to reflect what is actually happening in the gut.1Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. Intestinal bacterial, fungal, and methanogen overgrowth This is not just a labeling preference. The fact that methanogens are not bacteria explains why standard antibiotics that work well against hydrogen-producing bacteria often fail against methane producers.
Stool and breath analyses reveal strikingly different microbial communities between the two types. People with constipation-predominant symptoms and high breath methane harbor higher abundances of Methanobrevibacter along with hydrogen-producing families like Ruminococcaceae and Christensenellaceae that feed the methanogens. People with diarrhea-predominant symptoms and high breath hydrogen, meanwhile, show higher abundances of Enterobacteriaceae and lower overall microbial diversity.2PubMed Central. Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes These are fundamentally different ecosystems in the gut, not just different intensities of the same problem.
How Symptoms Split Along Gas Lines
The most consistent clinical finding across multiple studies is that methane maps to constipation and hydrogen maps to diarrhea. Patients whose breath tests show methane dominance are about five times more likely to have constipation than those with hydrogen dominance, and the severity of constipation tends to track with how much methane is being produced.3PubMed Central. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus Another study across IBS subtypes confirmed this split: methane levels were significantly higher in constipation-predominant patients, while hydrogen levels ran higher in those with diarrhea.4PubMed Central. Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (IBS): Correlating H(2) or CH(4) production with severity of IBS
The reason methane causes constipation is not just correlation. Animal studies show that methane gas directly slows small intestinal transit, by roughly 59 percent in one canine experiment, and it does this by ramping up the force of intestinal contractions. Stronger contractions in the small bowel sound like they should move things along faster, but what methane actually does is increase non-propulsive contractions, essentially squeezing the gut in a way that holds contents in place rather than pushing them forward.5PubMed. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity Separate experiments on guinea pig intestinal tissue confirmed the pattern: methane slowed peristaltic velocity while increasing contraction amplitude.6PubMed. The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time
Hydrogen-dominant overgrowth, by contrast, does not appear to have the same direct braking effect on the gut. The diarrhea associated with hydrogen SIBO likely results from a combination of bacterial fermentation producing osmotically active byproducts, damage to the intestinal lining, and bile acid disruption. Bloating is common in both types, but the constipation-versus-diarrhea divide is the clearest clinical clue about which gas is dominant before you ever see a breath test result. A recent analysis confirmed this predictive value: a diagnosis of IMO was positively associated with constipation and inversely associated with diarrhea, with diarrhea-predominant patients having less than half the odds of an IMO diagnosis compared to those with normal bowel habits.7PubMed Central. Can Symptoms and Medical History Predict Outcomes for Hydrogen and Methane Breath Testing?
Beyond Bowel Habits: Other Clinical Differences
The differences between hydrogen and methane SIBO extend beyond constipation and diarrhea. In a study of over 1,400 patients, hydrogen-producing SIBO was associated with vitamin B12 deficiency, diabetes, prior gallbladder removal, and a history of Roux-en-Y gastric bypass surgery. Methane-producing overgrowth showed none of these associations. The one factor that distinguished the two groups from each other, rather than from healthy patients, was vitamin B12: hydrogen SIBO was linked to B12 deficiency, while methane SIBO was not.8PubMed. Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens This makes biological sense. The bacteria driving hydrogen SIBO can consume B12 in the small intestine before your body absorbs it. Methanogens do not metabolize B12 in the same way.
There is also an interesting relationship between hydrogen SIBO and body weight. A study of non-constipation IBS patients found that those without SIBO had significantly higher BMI and waist circumference than those with SIBO. Obesity was inversely associated with hydrogen-producing overgrowth, with obese patients having less than half the odds of testing positive.9Journal of Korean Medical Science. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome When hydrogen SIBO was successfully eradicated with rifaximin, the leanest patients gained a small but statistically significant amount of weight, suggesting the bacterial overgrowth had been interfering with nutrient absorption or caloric harvest.10PubMed Central. Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change
How Breath Testing Tells Them Apart
The standard diagnostic approach is a breath test, which measures hydrogen and methane (and, increasingly, hydrogen sulfide) in your exhaled breath after you drink a sugar solution. Most clinicians use either lactulose or glucose as the test substrate. When bacteria ferment these sugars in the small intestine, the gases they produce enter the bloodstream and are exhaled through the lungs, where they can be measured.
The two substrates have different strengths. Glucose is absorbed quickly in the upper small intestine, so it is more specific for overgrowth in that area but may miss bacteria living further down. Lactulose is not absorbed at all and travels the entire intestine, which makes it more sensitive but less specific, because the gas spike from lactulose fermenting in the colon (where bacteria are supposed to be) can mimic a small intestinal signal. One comparison study found that lactulose flagged roughly 34 percent of IBS patients as positive, which was not significantly different from controls, while glucose flagged about 6 percent of IBS patients and under 1 percent of controls, making it better at distinguishing real overgrowth from noise.11PubMed. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome
The North American Consensus on breath testing established cut-off values: a rise in hydrogen of 20 or more parts per million above baseline within 90 minutes suggests hydrogen SIBO, while a methane level of 10 or more parts per million at any point during the test suggests IMO.12PubMed Central. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus The methane threshold applies at any time point, not just as a rise from baseline, because methanogens can produce methane even while fasting. A patient can test positive for both gases simultaneously, and about 11 percent of positive patients in one large cohort did produce both.13PubMed. Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens
Treatment Differs Sharply by Type
This is where getting the gas type right has the most immediate practical consequence. For hydrogen-dominant SIBO, the first-line treatment is typically rifaximin, a gut-targeted antibiotic that stays mostly in the intestine without entering the bloodstream in significant amounts. It works well against most hydrogen-producing bacteria.
For methane-dominant IMO, rifaximin alone is often not enough. The dominant methanogen, Methanobrevibacter smithii, is resistant to many antibiotics. In a study comparing treatment approaches, rifaximin by itself eradicated methane in only about 28 percent of patients. Adding neomycin to rifaximin pushed the methane eradication rate to 87 percent and lifted the clinical response rate to 85 percent, compared to 56 percent with rifaximin alone.14PubMed. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test A subsequent trial confirmed this advantage, showing that the combination significantly reduced constipation severity, straining, and bloating compared to neomycin with placebo.15PubMed. Antibiotic treatment of constipation-predominant irritable bowel syndrome A recent systematic review and meta-analysis affirmed that combination rifaximin-neomycin therapy yielded methane eradication rates around 87 percent and higher clinical response than either drug alone.16The Egyptian Journal of Internal Medicine. SIBO and intestinal methanogen overgrowth: breath test performance, treatment response, and relapse – a systematic review and meta-analysis
The disparity also showed up in a small group of patients with liver disease who were treated with rifaximin alone. Two out of three hydrogen-SIBO patients improved on the breath test, while only one out of five methane-SIBO patients did, reinforcing that methanogens simply do not respond well to rifaximin on its own.17PLOS ONE. Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function If you have methane-dominant overgrowth and your practitioner prescribes only rifaximin, this evidence suggests you may want to discuss adding a second agent.
Dietary Strategies and the Elemental Diet
Dietary approaches also depend on which type you are dealing with. Low-FODMAP diets, which restrict certain fermentable carbohydrates, can reduce hydrogen production. One controlled trial showed that a low-FODMAP diet significantly decreased fasting breath hydrogen levels, but methane levels did not change.18PLOS ONE. A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects This tracks with the biology: restricting the carbohydrates that hydrogen-producing bacteria feed on starves those organisms but does not directly target the methanogens that live downstream of them. A low-FODMAP diet can still help manage symptoms in methane patients by reducing overall gas production, but it is unlikely to resolve the underlying methanogen overgrowth.
The elemental diet is a more aggressive nutritional approach. It uses predigested, easily absorbed nutrients that leave essentially nothing for bacteria or archaea to ferment by the time the formula reaches the lower small intestine. A recent study found that a two-week exclusive elemental diet significantly dropped both maximum methane levels (from an average of 41 ppm to 12 ppm) and hydrogen levels (from 43 ppm to 12 ppm), with 73 percent of patients normalizing their breath tests.19PubMed. Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients With Intestinal Microbial Overgrowth A case report of a homemade elemental diet for methane-dominant overgrowth showed methane dropping from an average of 42 ppm to 3 ppm after 15 days, though levels partially rebounded after a second, shorter course.20PubMed Central. Homemade Elemental Diet to Treat Intestinal Methanogen Overgrowth: A Case Report The elemental diet is one of the few interventions that appears effective against both gas types, though it is demanding to follow and typically reserved for cases that do not respond to antibiotics.
Herbal Antimicrobials
Some patients and practitioners prefer herbal antimicrobials, either because of antibiotic concerns or because of insurance and cost barriers. A retrospective study found that a mix of herbal therapies produced a negative follow-up breath test in about 46 percent of patients, compared to 34 percent for rifaximin, a difference that was not statistically significant.21PubMed Central. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth The study pooled hydrogen and methane patients together, so it does not tell us whether herbal protocols work equally well against both types. Clinicians who use herbal antimicrobials for methane-dominant cases often add allicin (from garlic) or oregano oil, reasoning that these have some activity against archaea, but the evidence base for this specific application remains thin. The herbal approach is probably a reasonable alternative for hydrogen-dominant SIBO based on existing data, but anyone with confirmed methane dominance should be aware that the evidence supporting herbal protocols for IMO specifically is weaker than for antibiotic combinations.
Hydrogen Sulfide as a Third Type
The hydrogen-versus-methane framing has dominated SIBO discussions for years, but newer breath-testing devices can now measure a third gas: hydrogen sulfide. Hydrogen sulfide SIBO is driven by sulfate-reducing bacteria like Desulfovibrio and Fusobacterium species, which consume hydrogen and produce hydrogen sulfide, the gas that smells like rotten eggs.22PubMed Central. Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes
Clinically, hydrogen sulfide overgrowth tends to look more like hydrogen SIBO than methane IMO. Higher breath hydrogen sulfide levels correlate with more severe diarrhea, urgency, and abdominal pain.23PubMed Central. Real-world Study of Three-gas Breath Testing Nationwide and the Association With Symptoms But hydrogen sulfide can also cause a diagnostic blind spot. Because sulfate-reducing bacteria consume hydrogen, they can keep breath hydrogen levels deceptively low, sometimes producing a “flatline” hydrogen reading on a standard two-gas breath test. A case registry found that a flatline hydrogen pattern on the lactulose breath test was the most common diagnostic clue, used in about 43 percent of diagnoses.24medRxiv. Hydrogen sulfide small intestinal bacterial overgrowth case registry If your breath test shows neither hydrogen nor methane rising, but you still have significant GI symptoms, hydrogen sulfide overgrowth is worth considering.
Why Recurrence Is So Common
One of the most frustrating aspects of both hydrogen SIBO and methane IMO is how often they come back after successful treatment. This is because treatment addresses the overgrowth itself without necessarily fixing what allowed the overgrowth to develop. The migrating motor complex (MMC), a cyclical pattern of intestinal contractions that sweeps debris and bacteria down through the small intestine between meals, is considered the gut’s housekeeping mechanism. When this sweeping action is impaired, bacteria and archaea accumulate in the small intestine. Conditions that disrupt the MMC, including diabetes, surgical adhesions, prior abdominal surgery, hypothyroidism, and chronic opioid use, create the conditions for recurrence regardless of how thoroughly the overgrowth was cleared.
Methane IMO may be particularly prone to relapse because methanogens form biofilms and can be difficult to eradicate completely, meaning even a short course of antibiotics may leave enough organisms to repopulate once the treatment stops. Addressing the root cause, whether that means managing blood sugar, tapering off proton pump inhibitors, or using prokinetic agents to keep the MMC functioning, is essential for long-term management of either type.
A Word About Probiotics
Probiotics are widely marketed for gut health, but their role in SIBO is complicated. There is a case report of a commercial airline pilot who began taking a multi-strain probiotic and, within five days, developed worsening abdominal symptoms along with difficulty concentrating and mental fatigue. The symptoms resolved after he stopped the probiotic and took rifaximin.25PubMed Central. Clear Skies, Cloudy Mind: Probiotic-Related Brain Fogginess in a Commercial Airline Pilot A broader investigation found that probiotics designed to deliver bacteria to the colon may instead colonize the small bowel, especially in people with slow motility or low stomach acid, effectively worsening the overgrowth.26PubMed Central. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis Some of those bacteria turned out to be resistant to routine antibiotics, making subsequent treatment harder. This does not mean all probiotics are harmful for all SIBO patients, but it does mean that blindly adding a multi-strain probiotic to an already overgrown small intestine can backfire. If you have confirmed SIBO of either type and are considering probiotics, it is worth discussing timing and strain selection with a practitioner who understands the specific microbial dynamics involved.